Trial of a blood product for heparin resistance during heart surgery
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for heart surgery that uses a heart-lung machine.
- You have a condition called heparin resistance (your blood does not thin enough with a high dose of heparin).
- You are between 18 and 85 years old.
- You can provide written or electronic consent to join the study.
- If you can become pregnant, you must have a negative pregnancy test within 2 weeks before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a protein in your blood (antithrombin) can predict if you'll have trouble with the blood thinner heparin during heart surgery. If you qualify, it might help doctors personalize your care to reduce bleeding or clotting risks during and after surgery.
This study compares two blood thinners, bivalirudin and heparin, given during a heart procedure to open blocked arteries (PCI). It aims to find which one is safer for people at high risk of bleeding.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This trial tests whether giving heparin (a blood thinner) during a specific type of heart procedure is safer and works better than not giving it. It focuses on patients where the blood supply in the hand’s artery connection is functioning properly.
This Phase 2 trial studies whether giving antithrombin can better prevent harmful blood clots (venous thromboembolism) after serious injuries. The goal is to reduce clot risk while you’re in the trauma ICU or step-down unit.
This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.
Hear when a new Acquired Antithrombin Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.